Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intersect Ent, Inc. (XENT) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Intersect Ent, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1271214.
Total stock buying since 2014: $612,500.
Total stock sales since 2014: $36,496,675.
Total stock option exercises since 2014: $6,642,882.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 0 | $0 | 12,500 | $9,000 |
| 2020 | 34,035 | $325,890 | 0 | $0 | 0 | $0 |
| 2019 | 0 | $0 | 168,230 | $4,904,180 | 142,353 | $2,188,706 |
| 2018 | 3,811 | $99,943 | 361,790 | $12,280,722 | 249,666 | $2,589,773 |
| 2017 | 0 | $0 | 408,499 | $10,891,020 | 225,000 | $1,638,635 |
| 2016 | 8,000 | $101,112 | 130,559 | $2,299,635 | 84,541 | $71,266 |
| 2015 | 0 | $0 | 246,194 | $6,121,118 | 57,179 | $44,752 |
| 2014 | 5,000 | $85,555 | 0 | $0 | 16,250 | $100,750 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-01 | 0 | $0 | 0 | $0 | 12,500 | $9,000 |
| 2020-03 | 34,035 | $325,890 | 0 | $0 | 0 | $0 |
| 2019-11 | 0 | $0 | 25,584 | $551,079 | 21,937 | $387,626 |
| 2019-06 | 0 | $0 | 350 | $8,750 | 350 | $4,567 |
| 2019-05 | 0 | $0 | 23,850 | $686,802 | 23,850 | $355,792 |
| 2019-04 | 0 | $0 | 118,446 | $3,657,549 | 96,216 | $1,440,721 |
| 2018-12 | 0 | $0 | 20,000 | $594,500 | 45,000 | $113,250 |
| 2018-10 | 0 | $0 | 32,833 | $951,879 | 17,833 | $220,336 |
| 2018-09 | 0 | $0 | 32,833 | $954,016 | 17,833 | $207,952 |
| 2018-08 | 3,811 | $99,943 | 20,000 | $530,200 | 5,000 | $65,250 |
| 2018-07 | 0 | $0 | 27,000 | $906,806 | 12,000 | $156,600 |
| 2018-06 | 0 | $0 | 32,833 | $1,270,868 | 17,833 | $207,952 |
| 2018-05 | 0 | $0 | 27,833 | $1,100,802 | 27,833 | $338,452 |
| 2018-04 | 0 | $0 | 27,833 | $1,077,177 | 27,833 | $338,452 |
| 2018-03 | 0 | $0 | 27,833 | $1,035,759 | 27,833 | $338,452 |
| 2018-02 | 0 | $0 | 28,791 | $1,040,983 | 27,833 | $338,452 |
| 2018-01 | 0 | $0 | 84,001 | $2,817,732 | 22,835 | $264,625 |
| 2017-12 | 0 | $0 | 59,518 | $1,905,320 | 50,833 | $793,102 |
| 2017-11 | 0 | $0 | 47,833 | $1,345,716 | 22,833 | $154,702 |
| 2017-10 | 0 | $0 | 32,833 | $951,842 | 22,833 | $154,702 |
| 2017-09 | 0 | $0 | 46,472 | $1,397,534 | 22,833 | $154,702 |
| 2017-08 | 0 | $0 | 55,258 | $1,665,718 | 22,833 | $154,702 |
| 2017-07 | 0 | $0 | 45,335 | $1,282,568 | 22,835 | $154,725 |
| 2017-06 | 0 | $0 | 20,000 | $521,980 | 10,000 | $12,000 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-19 | Moll Frederic H | Option Ex | 12,500 | .72 | 9,000 |
| 2020-03-17 | West Thomas A. (President and CEO) | Buy | 19,035 | 8.48 | 161,435 |
| 2020-03-17 | Meier Richard A (EVP & Chief Financial Officer) | Buy | 5,000 | 7.80 | 38,995 |
| 2020-03-16 | Meier Richard A (EVP & Chief Financial Officer) | Buy | 10,000 | 12.55 | 125,460 |
| 2019-11-05 | Binney Robert H Jr (Chief Commercial Officer) | Sale | 25,584 | 21.54 | 551,079 |
| 2019-11-05 | Binney Robert H Jr (Chief Commercial Officer) | Option Ex | 21,937 | 17.67 | 387,626 |
| 2019-06-13 | Stimson Susan P (Chief Strategy Officer) | Sale | 350 | 25.00 | 8,750 |
| 2019-06-13 | Stimson Susan P (Chief Strategy Officer) | Option Ex | 350 | 13.05 | 4,567 |
| 2019-05-15 | Earnhardt Lisa D (President and CEO) | Sale | 9,500 | 25.59 | 243,105 |
| 2019-05-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 9,500 | 13.05 | 123,975 |
| 2019-05-10 | Stimson Susan P (Chief Strategy Officer) | Sale | 5,350 | 27.38 | 146,499 |
| 2019-05-10 | Stimson Susan P (Chief Strategy Officer) | Option Ex | 5,350 | 13.05 | 69,817 |
| 2019-05-06 | Lehman David Aaron (General Counsel) | Sale | 9,000 | 33.02 | 297,198 |
| 2019-05-06 | Lehman David Aaron (General Counsel) | Option Ex | 9,000 | 18.00 | 162,000 |
| 2019-04-29 | Stimson Susan P (Chief Strategy Officer) | Sale | 12,500 | 31.06 | 388,250 |
| 2019-04-29 | Stimson Susan P (Chief Strategy Officer) | Option Ex | 12,500 | 21.06 | 263,250 |
| 2019-04-29 | Lehman David Aaron (General Counsel) | Sale | 9,000 | 33.04 | 297,341 |
| 2019-04-29 | Lehman David Aaron (General Counsel) | Option Ex | 9,000 | 18.00 | 162,000 |
| 2019-04-23 | Stimson Susan P (Chief Strategy Officer) | Sale | 2,663 | 30.00 | 79,890 |
| 2019-04-15 | Earnhardt Lisa D (President and CEO) | Sale | 29,588 | 28.43 | 841,246 |
| 2019-04-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 13,516 | 7.12 | 96,301 |
| 2019-04-10 | Stimson Susan P (Chief Strategy Officer) | Sale | 10,000 | 29.13 | 291,320 |
| 2019-04-10 | Stimson Susan P (Chief Strategy Officer) | Option Ex | 10,000 | 18.90 | 189,000 |
| 2019-04-02 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 21,200 | 32.34 | 685,650 |
| 2019-04-02 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 21,200 | 15.97 | 338,670 |
| 2019-04-01 | Binney Robert H Jr (Chief Commercial Officer) | Sale | 3,495 | 31.98 | 111,752 |
| 2019-04-01 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 30,000 | 32.07 | 962,100 |
| 2019-04-01 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 30,000 | 13.05 | 391,500 |
| 2018-12-31 | Stimson Susan P (Chief Strategy Officer) | Option Ex | 5,000 | 1.20 | 6,000 |
| 2018-12-20 | Earnhardt Lisa D (President and CEO) | Option Ex | 35,000 | 1.20 | 42,000 |
| 2018-12-17 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 29.73 | 594,500 |
| 2018-12-17 | Earnhardt Lisa D (President and CEO) | Option Ex | 5,000 | 13.05 | 65,250 |
| 2018-10-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 29.63 | 592,620 |
| 2018-10-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 5,000 | 13.05 | 65,250 |
| 2018-10-08 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 28.00 | 359,259 |
| 2018-10-08 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 12.09 | 155,086 |
| 2018-09-17 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 29.14 | 582,860 |
| 2018-09-17 | Earnhardt Lisa D (President and CEO) | Option Ex | 5,000 | 13.05 | 65,250 |
| 2018-09-14 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 28.92 | 371,156 |
| 2018-09-14 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2018-08-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 26.51 | 530,200 |
| 2018-08-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 5,000 | 13.05 | 65,250 |
| 2018-08-06 | Mead Dana G Jr. | Buy | 3,811 | 26.23 | 99,943 |
| 2018-07-16 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 33.08 | 661,680 |
| 2018-07-16 | Earnhardt Lisa D (President and CEO) | Option Ex | 5,000 | 13.05 | 65,250 |
| 2018-07-10 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 7,000 | 35.02 | 245,126 |
| 2018-07-10 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Option Ex | 7,000 | 13.05 | 91,350 |
| 2018-06-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 36.79 | 735,720 |
| 2018-06-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 5,000 | 13.05 | 65,250 |
| 2018-06-05 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 41.70 | 535,148 |
| 2018-06-05 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2018-05-15 | Earnhardt Lisa D (President and CEO) | Sale | 15,000 | 39.22 | 588,240 |
| 2018-05-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 15,000 | 13.05 | 195,750 |
| 2018-05-03 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 39.94 | 512,562 |
| 2018-05-03 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2018-04-16 | Earnhardt Lisa D (President and CEO) | Sale | 15,000 | 39.59 | 593,925 |
| 2018-04-16 | Earnhardt Lisa D (President and CEO) | Option Ex | 15,000 | 13.05 | 195,750 |
| 2018-04-03 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 37.66 | 483,252 |
| 2018-04-03 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2018-03-15 | Earnhardt Lisa D (President and CEO) | Sale | 15,000 | 38.32 | 574,785 |
| 2018-03-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 15,000 | 13.05 | 195,750 |
| 2018-03-06 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 35.92 | 460,974 |
| 2018-03-06 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2018-02-15 | Earnhardt Lisa D (President and CEO) | Sale | 15,000 | 36.40 | 545,940 |
| 2018-02-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 15,000 | 13.05 | 195,750 |
| 2018-02-06 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 35.80 | 459,395 |
| 2018-02-06 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2018-02-01 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 958 | 37.21 | 35,648 |
| 2018-01-18 | Earnhardt Lisa D (President and CEO) | Sale | 11,166 | 33.47 | 373,692 |
| 2018-01-17 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 25,000 | 32.98 | 824,499 |
| 2018-01-16 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 25,000 | 33.69 | 842,174 |
| 2018-01-12 | Carscadden Gwen R. (Chief People Officer) | Sale | 10,000 | 34.35 | 343,480 |
| 2018-01-12 | Carscadden Gwen R. (Chief People Officer) | Option Ex | 10,000 | 12.19 | 121,900 |
| 2018-01-11 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,835 | 33.80 | 433,887 |
| 2018-01-11 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,835 | 11.12 | 142,725 |
| 2017-12-15 | Earnhardt Lisa D (President and CEO) | Sale | 10,685 | 31.87 | 340,509 |
| 2017-12-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 2,000 | 1.20 | 2,400 |
| 2017-12-11 | Lehman David Aaron (General Counsel) | Sale | 36,000 | 32.75 | 1,179,000 |
| 2017-12-11 | Lehman David Aaron (General Counsel) | Option Ex | 36,000 | 18.00 | 648,000 |
| 2017-12-04 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 30.06 | 385,811 |
| 2017-12-04 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2017-11-20 | Moll Frederic H | Sale | 2,500 | 28.76 | 71,895 |
| 2017-11-17 | Moll Frederic H | Sale | 5,000 | 28.74 | 143,710 |
| 2017-11-16 | Moll Frederic H | Sale | 6,700 | 28.77 | 192,765 |
| 2017-11-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 27.88 | 557,620 |
| 2017-11-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 10,000 | 1.20 | 12,000 |
| 2017-11-10 | Moll Frederic H | Sale | 800 | 29.00 | 23,200 |
| 2017-11-06 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 27.78 | 356,526 |
| 2017-11-06 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2017-10-16 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 28.37 | 567,340 |
| 2017-10-16 | Earnhardt Lisa D (President and CEO) | Option Ex | 10,000 | 1.20 | 12,000 |
| 2017-10-04 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 29.96 | 384,502 |
| 2017-10-04 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2017-09-25 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 13,639 | 28.98 | 395,190 |
| 2017-09-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 30.19 | 603,880 |
| 2017-09-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 10,000 | 1.20 | 12,000 |
| 2017-09-05 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 31.05 | 398,464 |
| 2017-09-05 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2017-08-28 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 2,425 | 30.00 | 72,750 |
| 2017-08-25 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 20,000 | 30.25 | 604,940 |
| 2017-08-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 30.79 | 615,820 |
| 2017-08-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 10,000 | 1.20 | 12,000 |
| 2017-08-04 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,833 | 29.00 | 372,208 |
| 2017-08-04 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,833 | 11.12 | 142,702 |
| 2017-07-25 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 12,500 | 28.25 | 353,112 |
| 2017-07-17 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 29.03 | 580,640 |
| 2017-07-17 | Earnhardt Lisa D (President and CEO) | Option Ex | 10,000 | 1.20 | 12,000 |
| 2017-07-10 | Hilleman Jeryl L (Chief Financial Officer) | Sale | 12,835 | 27.18 | 348,816 |
| 2017-07-10 | Hilleman Jeryl L (Chief Financial Officer) | Option Ex | 12,835 | 11.12 | 142,725 |
| 2017-06-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 26.10 | 521,980 |
| 2017-06-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 10,000 | 1.20 | 12,000 |
| 2017-05-22 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 20,000 | 22.87 | 457,380 |
| 2017-05-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 22.98 | 459,520 |
| 2017-05-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 10,000 | 1.20 | 12,000 |
| 2017-04-20 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 1,250 | 17.25 | 21,562 |
| 2017-04-17 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 16.06 | 321,240 |
| 2017-04-17 | Earnhardt Lisa D (President and CEO) | Option Ex | 10,000 | 1.20 | 12,000 |
| 2017-03-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 15.02 | 300,460 |
| 2017-03-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 10,000 | 1.20 | 12,000 |
| 2017-02-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 13.01 | 260,180 |
| 2017-02-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 20,000 | 1.20 | 24,000 |
| 2016-10-20 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 3,603 | 16.58 | 59,744 |
| 2016-10-17 | Earnhardt Lisa D (President and CEO) | Sale | 400 | 18.00 | 7,200 |
| 2016-10-17 | Earnhardt Lisa D (President and CEO) | Option Ex | 400 | 1.20 | 480 |
| 2016-09-07 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Sale | 8,664 | 15.67 | 135,773 |
| 2016-09-07 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Option Ex | 8,664 | .72 | 6,238 |
| 2016-09-06 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Sale | 20,000 | 15.90 | 317,940 |
| 2016-09-06 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Option Ex | 20,000 | .72 | 14,400 |
| 2016-09-06 | Stambaugh James (VP Clinical Affairs) | Sale | 3,700 | 16.00 | 59,200 |
| 2016-09-02 | Stambaugh James (VP Clinical Affairs) | Sale | 300 | 16.00 | 4,800 |
| 2016-08-03 | Stambaugh James (VP Clinical Affairs) | Sale | 3,977 | 17.00 | 67,609 |
| 2016-08-03 | Stambaugh James (VP Clinical Affairs) | Option Ex | 3,977 | .48 | 1,908 |
| 2016-07-18 | Stambaugh James (VP Clinical Affairs) | Sale | 5,000 | 15.33 | 76,645 |
| 2016-07-18 | Stambaugh James (VP Clinical Affairs) | Option Ex | 5,000 | .48 | 2,400 |
| 2016-06-13 | Stambaugh James (VP Clinical Affairs) | Sale | 500 | 14.38 | 7,191 |
| 2016-05-16 | Gallahue Kieran | Buy | 8,000 | 12.64 | 101,112 |
| 2016-04-27 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Sale | 2,000 | 20.01 | 40,016 |
| 2016-04-27 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Option Ex | 2,000 | .72 | 1,440 |
| 2016-04-20 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 3,603 | 18.86 | 67,934 |
| 2016-04-18 | Earnhardt Lisa D (President and CEO) | Sale | 8,500 | 19.50 | 165,741 |
| 2016-04-18 | Earnhardt Lisa D (President and CEO) | Option Ex | 4,000 | 1.20 | 4,800 |
| 2016-04-15 | Earnhardt Lisa D (President and CEO) | Sale | 20,000 | 18.34 | 366,840 |
| 2016-04-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 20,000 | 1.20 | 24,000 |
| 2016-03-21 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 3,603 | 16.51 | 59,485 |
| 2016-03-15 | Earnhardt Lisa D (President and CEO) | Sale | 9,000 | 18.01 | 162,081 |
| 2016-03-14 | Moll Frederic H | Sale | 1,299 | 18.53 | 24,066 |
| 2016-03-08 | Moll Frederic H | Sale | 601 | 18.56 | 11,153 |
| 2016-03-03 | Moll Frederic H | Sale | 12,500 | 18.32 | 229,000 |
| 2016-03-03 | Moll Frederic H | Option Ex | 12,500 | .48 | 6,000 |
| 2016-02-22 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 3,603 | 18.65 | 67,203 |
| 2016-01-21 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 3,603 | 17.87 | 64,392 |
| 2016-01-20 | Kaufman Richard E (Sr VP& Chief Operating Officer) | Sale | 3,603 | 17.99 | 64,810 |
| 2016-01-15 | Earnhardt Lisa D (President and CEO) | Sale | 12,500 | 19.27 | 240,812 |
| 2016-01-15 | Earnhardt Lisa D (President and CEO) | Option Ex | 8,000 | 1.20 | 9,600 |
| 2015-12-28 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Option Ex | 5,700 | .72 | 4,104 |
| 2015-12-15 | Earnhardt Lisa D (President and CEO) | Sale | 6,820 | 19.86 | 135,411 |
| 2015-11-16 | Earnhardt Lisa D (President and CEO) | Sale | 6,818 | 18.00 | 122,730 |
| 2015-10-15 | Earnhardt Lisa D (President and CEO) | Sale | 6,818 | 18.72 | 127,619 |
| 2015-09-15 | Earnhardt Lisa D (President and CEO) | Sale | 6,818 | 25.99 | 177,227 |
| 2015-09-11 | Moll Frederic H | Sale | 10,000 | 25.21 | 252,109 |
| 2015-09-02 | Stambaugh James (VP Clinical Affairs) | Option Ex | 4,000 | .48 | 1,920 |
| 2015-08-17 | Earnhardt Lisa D (President and CEO) | Sale | 6,818 | 28.51 | 194,387 |
| 2015-07-20 | Stambaugh James (VP Clinical Affairs) | Sale | 12,000 | 30.52 | 366,204 |
| 2015-07-20 | Stambaugh James (VP Clinical Affairs) | Option Ex | 12,000 | .48 | 5,760 |
| 2015-07-15 | Earnhardt Lisa D (President and CEO) | Sale | 19,318 | 29.62 | 572,160 |
| 2015-06-15 | Earnhardt Lisa D (President and CEO) | Sale | 19,318 | 29.30 | 565,998 |
| 2015-05-15 | Kaufman Richard E (See Remarks) | Sale | 8,000 | 23.97 | 191,768 |
| 2015-05-15 | Earnhardt Lisa D (President and CEO) | Sale | 19,318 | 23.69 | 457,624 |
| 2015-05-11 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Sale | 80 | 23.10 | 1,848 |
| 2015-05-11 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Option Ex | 80 | .72 | 57 |
| 2015-05-08 | Stambaugh James (VP Clinical Affairs) | Sale | 2,785 | 23.87 | 66,469 |
| 2015-04-15 | Earnhardt Lisa D (See Remarks) | Sale | 19,318 | 25.96 | 501,553 |
| 2015-04-13 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Sale | 16,000 | 26.25 | 419,920 |
| 2015-04-13 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Option Ex | 16,000 | .81 | 13,008 |
| 2015-04-01 | Stambaugh James (VP Clinical Affairs) | Sale | 8,343 | 25.50 | 212,746 |
| 2015-03-16 | Earnhardt Lisa D (See Remarks) | Sale | 19,318 | 23.56 | 455,054 |
| 2015-03-11 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Sale | 8,000 | 23.06 | 184,496 |
| 2015-03-11 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Option Ex | 8,000 | 1.00 | 8,000 |
| 2015-03-09 | Stambaugh James (VP Clinical Affairs & Reimb.) | Sale | 8,343 | 23.02 | 192,030 |
| 2015-02-17 | Earnhardt Lisa D (See Remarks) | Sale | 19,318 | 22.69 | 438,344 |
| 2015-02-12 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Sale | 5,099 | 22.16 | 112,993 |
| 2015-02-12 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Option Ex | 5,099 | 1.00 | 5,099 |
| 2015-02-11 | Wolbeck Amy (V.P. Regulatory Affairs & Qlty) | Sale | 2,901 | 22.05 | 63,967 |
| 2015-02-02 | Stambaugh James (VP Clinical Affairs & Reimb.) | Sale | 8,343 | 20.98 | 175,002 |
| 2015-01-26 | Binney Robert H Jr (Vice President, Sales) | Sale | 6,300 | 21.18 | 133,459 |
| 2015-01-26 | Binney Robert H Jr (Vice President, Sales) | Option Ex | 6,300 | 1.08 | 6,804 |
| 2014-09-11 | Lucchese Cynthia L (Director) | Buy | 5,000 | 17.11 | 85,555 |
| 2014-08-06 | Moll Frederic H (Director) | Option Ex | 16,250 | 6.20 | 100,750 |
Insider trading activities including stock purchases, stock sales, and option exercises of XENT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Intersect Ent, Inc. (symbol XENT, CIK number 1271214) see the Securities and Exchange Commission (SEC) website.